Showing 181 - 200 results of 100,398 for search '(( 5 ((((we decrease) OR (nn decrease))) OR (a decrease)) ) OR ( end point decrease ))', query time: 1.33s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184

    Overexpression of Pax6 decreases Olig2 protein levels. by Eun Sook Jang (217069)

    Published 2011
    “…(<b>a</b>) Oli-Neu cells were transfected with flag-tagged WT Pax6 (WT), Pax6(5a)R128C (128), or eGFP control vector (-). …”
  5. 185
  6. 186
  7. 187
  8. 188

    OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

    Published 2019
    “…After 4 weeks, when the tumor size was approximately 100 mm<sup>3</sup> (T<sub>0</sub>) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”
  9. 189
  10. 190

    Effects of conivaptan on brain water content (BWC), blood-brain-barrier (BBB) disruption, plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

    Published 2015
    “…Following MCAO, Evans Blue (EB) extravasation index (I/C) was increased in vehicle treated mice, and reduced in conivaptan treated mice, naïve, n = 5, vehicle, n = 8, Conivaptan 0.2 mg, n = 8. (C, D) Conivaptan treatment of 0.2 mg resulted in an elevation of plasma sodium and osmolality, and decreased urine sodium and osmolality due to aquaresis. …”
  11. 191
  12. 192
  13. 193
  14. 194

    Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  15. 195

    Image_1_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpeg by Mohamed Khass (695111)

    Published 2023
    “…In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  16. 196

    Image_1_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpeg by Mohamed Khass (695111)

    Published 2022
    “…In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  17. 197

    Image_2_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpeg by Mohamed Khass (695111)

    Published 2023
    “…In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  18. 198

    Image_3_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpg by Mohamed Khass (695111)

    Published 2022
    “…In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  19. 199

    Image_3_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpg by Mohamed Khass (695111)

    Published 2023
    “…In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”
  20. 200

    Image_2_Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging.jpeg by Mohamed Khass (695111)

    Published 2022
    “…In contrast, at six months of age and thereafter, λ5<sup>-/-</sup> and J<sub>H</sub><sup>-/-</sup>λ5<sup>-/-</sup> mice demonstrated a severe decrease in trabecular bone mass. …”